المؤلفون: Ooi J.D., Eggenhuizen P.J., Ng B.H.

مصطلحات الفهرس: Crohn disease/th [Therapy], dendritic cell, DNA immunization, DNA vector, drug targeting, effector cell, fecal microbiota transplantation, graft rejection, immunological tolerance, insulin dependent diabetes mellitus/dt [Drug Therapy], insulin dependent diabetes mellitus/et [Etiology], low drug dose, microbiome, multiple sclerosis/et [Etiology], nonhuman, pemphigus/th [Therapy], phenotype, regulatory T lymphocyte, review, skin lupus erythematosus/th [Therapy], synergistic effect, systemic lupus erythematosus/et [Etiology], T lymphocyte subpopulation, transient expression, treatment outcome, umbilical cord blood, aldesleukin/dt [Drug Therapy], autoantigen, bacterial polysaccharide, beta glucan, butyric acid, CD135 antigen, chimeric antigen receptor/ec [Endogenous Compound], corticosteroid/dt [Drug Therapy], cytokine receptor agonist/dt [Drug Therapy], cytokine receptor agonist/pd [Pharmacology], cytotoxic T lymphocyte antigen 4/ec [Endogenous Compound], Flt3 ligand/cb [Drug Combination], Flt3 ligand/it [Drug Interaction], Flt3 ligand/dt [Drug Therapy], galactan, immunosuppressive agent/dt [Drug Therapy], insulin/dt [Drug Therapy], interleukin 10/dt [Drug Therapy], interleukin 10/pd [Pharmacology], major histocompatibility antigen/ec [Endogenous Compound], mammalian target of rapamycin/ec [Endogenous Compound], mammalian target of rapamycin inhibitor/dt [Drug Therapy], mammalian target of rapamycin inhibitor/pd [Pharmacology], methylprednisolone/do [Drug Dose], methylprednisolone/dt [Drug Therapy], mycophenolic acid/do [Drug Dose], mycophenolic acid/dt [Drug Therapy], nanoparticle, peptide/dt [Drug Therapy], rapamycin/cb [Drug Combination], rapamycin/it [Drug Interaction], rapamycin/dt [Drug Therapy], rapamycin/pd [Pharmacology], recombinant interleukin 2/do [Drug Dose], recombinant interleukin 2/dt [Drug Therapy], short chain fatty acid, T lymphocyte receptor/ec [Endogenous Compound], tacrolimus/do [Drug Dose], tacrolimus/dt [Drug Therapy], transcription factor FOXP3/ec [Endogenous Compound], tumor necrosis factor receptor 2/ec [Endogenous Compound], unclassified drug, tumor necrosis factor receptor 2 agonist/dt [Drug Therapy], tumor necrosis factor receptor 2 agonist/pd [Pharmacology], human, adverse event, antigen specificity, antiinflammatory activity, autoimmune disease/dt [Drug Therapy], autoimmune disease/et [Etiology], autoimmune disease/pc [Prevention], autoimmune disease/th [Therapy], autoimmune hepatitis/th [Therapy], autoimmunity, Bifidobacterium bifidum, biological therapy, CD4+ T lymphocyte, cell therapy, chimeric antigen receptor immunotherapy, chronic inflammation, Review

URL: International Journal of Molecular Sciences
Click here for full text options
LibKey Link

المؤلفون: Ooi J.D., Eggenhuizen P.J., Ng B.H.

مصطلحات الفهرس: Crohn disease/th [Therapy], dendritic cell, DNA immunization, DNA vector, drug targeting, effector cell, fecal microbiota transplantation, graft rejection, immunological tolerance, insulin dependent diabetes mellitus/dt [Drug Therapy], insulin dependent diabetes mellitus/et [Etiology], low drug dose, microbiome, multiple sclerosis/et [Etiology], nonhuman, pemphigus/th [Therapy], phenotype, regulatory T lymphocyte, review, skin lupus erythematosus/th [Therapy], synergistic effect, systemic lupus erythematosus/et [Etiology], T lymphocyte subpopulation, transient expression, treatment outcome, umbilical cord blood, aldesleukin/dt [Drug Therapy], autoantigen, bacterial polysaccharide, beta glucan, butyric acid, CD135 antigen, chimeric antigen receptor/ec [Endogenous Compound], corticosteroid/dt [Drug Therapy], cytokine receptor agonist/dt [Drug Therapy], cytokine receptor agonist/pd [Pharmacology], cytotoxic T lymphocyte antigen 4/ec [Endogenous Compound], Flt3 ligand/cb [Drug Combination], Flt3 ligand/it [Drug Interaction], Flt3 ligand/dt [Drug Therapy], galactan, immunosuppressive agent/dt [Drug Therapy], insulin/dt [Drug Therapy], interleukin 10/dt [Drug Therapy], interleukin 10/pd [Pharmacology], major histocompatibility antigen/ec [Endogenous Compound], mammalian target of rapamycin/ec [Endogenous Compound], mammalian target of rapamycin inhibitor/dt [Drug Therapy], mammalian target of rapamycin inhibitor/pd [Pharmacology], methylprednisolone/do [Drug Dose], methylprednisolone/dt [Drug Therapy], mycophenolic acid/do [Drug Dose], mycophenolic acid/dt [Drug Therapy], nanoparticle, peptide/dt [Drug Therapy], rapamycin/cb [Drug Combination], rapamycin/it [Drug Interaction], rapamycin/dt [Drug Therapy], rapamycin/pd [Pharmacology], recombinant interleukin 2/do [Drug Dose], recombinant interleukin 2/dt [Drug Therapy], short chain fatty acid, T lymphocyte receptor/ec [Endogenous Compound], tacrolimus/do [Drug Dose], tacrolimus/dt [Drug Therapy], transcription factor FOXP3/ec [Endogenous Compound], tumor necrosis factor receptor 2/ec [Endogenous Compound], unclassified drug, tumor necrosis factor receptor 2 agonist/dt [Drug Therapy], tumor necrosis factor receptor 2 agonist/pd [Pharmacology], human, adverse event, antigen specificity, antiinflammatory activity, autoimmune disease/dt [Drug Therapy], autoimmune disease/et [Etiology], autoimmune disease/pc [Prevention], autoimmune disease/th [Therapy], autoimmune hepatitis/th [Therapy], autoimmunity, Bifidobacterium bifidum, biological therapy, CD4+ T lymphocyte, cell therapy, chimeric antigen receptor immunotherapy, chronic inflammation, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/29021
International Journal of Molecular Sciences
LibKey Link

المؤلفون: Brown M.A., Zochling J., Newell F., Charlesworth J.C., Leo P., Lester S., Proudman S., Stankovich J., Cortes A., Zhou Y., Stevens W., Sahhar J., Roddy J., Nash P., Tymms K., Rischmueller M.

مصطلحات الفهرس: VCAM1 gene, gene replication, adult, article, Australian, cohort analysis, controlled study, disease predisposition, female, gene, gene locus, genetic association, genetic variability, genotype, human, major clinical study, male, microarray kit, pathogenesis, pilot study, scleroderma/et [Etiology], single nucleotide polymorphism, systemic lupus erythematosus/et [Etiology], centromere antibody/ec [Endogenous Compound], HLA DRB1 antigen/ec [Endogenous Compound], STAT4 protein/ec [Endogenous Compound], vascular cell adhesion molecule 1/ec [Endogenous Compound], DNASE1L3 gene, HLA DRB1 gene, STAT4 gene, TNP03 IRF5 gene, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/42444
Arthritis Research and Therapy
Click here for full text options
LibKey Link

المؤلفون: Ghali J.R., Kitching A.R., Holdsworth S.R., Wang Y.M.

مصطلحات الفهرس: drug efficacy, drug response, gene, glomerulonephritis/et [Etiology], human, humoral immunity, immune response, immunological tolerance, immunoregulation, innate immunity, lymphocyte count, lymphocyte proliferation, nonhuman, pathogenesis, priority journal, protein expression, proteinuria/dt [Drug Therapy], proteinuria/et [Etiology], regulatory T lymphocyte, systemic lupus erythematosus/dt [Drug Therapy], systemic lupus erythematosus/et [Etiology], upregulation, cyclophosphamide/dt [Drug Therapy], cytotoxic T lymphocyte antigen 4/ec [Endogenous Compound], gamma interferon/ec [Endogenous Compound], glucocorticoid/dt [Drug Therapy], immunoglobulin G/ec [Endogenous Compound], interleukin 10/dt [Drug Therapy], interleukin 10/ec [Endogenous Compound], interleukin 2/ct [Clinical Trial], interleukin 2/dt [Drug Therapy], rituximab/dt [Drug Therapy], STAT3 protein/ec [Endogenous Compound], FOXP3 gene, protein depletion, acute kidney failure/dt [Drug Therapy], acute kidney failure/et [Etiology], ANCA associated vasculitis/dt [Drug Therapy], ANCA associated vasculitis/et [Etiology], antigen expression, apoptosis, article, autoimmunity, CD25+ T lymphocyte, CD4+ T lymphocyte, CD8+ T lymphocyte, cell infiltration, cell therapy, cytokine production, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/39912
Nephrology
Click here for full text options
LibKey Link

المؤلفون: Brown M.A., Zochling J., Newell F., Charlesworth J.C., Leo P., Lester S., Proudman S., Stankovich J., Cortes A., Zhou Y., Stevens W., Sahhar J., Roddy J., Nash P., Tymms K., Rischmueller M.

مصطلحات الفهرس: VCAM1 gene, gene replication, adult, article, Australian, cohort analysis, controlled study, disease predisposition, female, gene, gene locus, genetic association, genetic variability, genotype, human, major clinical study, male, microarray kit, pathogenesis, pilot study, scleroderma/et [Etiology], single nucleotide polymorphism, systemic lupus erythematosus/et [Etiology], centromere antibody/ec [Endogenous Compound], HLA DRB1 antigen/ec [Endogenous Compound], STAT4 protein/ec [Endogenous Compound], vascular cell adhesion molecule 1/ec [Endogenous Compound], DNASE1L3 gene, HLA DRB1 gene, STAT4 gene, TNP03 IRF5 gene, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/42444
Arthritis Research and Therapy
LibKey Link

المؤلفون: Ghali J.R., Kitching A.R., Holdsworth S.R., Wang Y.M.

مصطلحات الفهرس: drug efficacy, drug response, gene, glomerulonephritis/et [Etiology], human, humoral immunity, immune response, immunological tolerance, immunoregulation, innate immunity, lymphocyte count, lymphocyte proliferation, nonhuman, pathogenesis, priority journal, protein expression, proteinuria/dt [Drug Therapy], proteinuria/et [Etiology], regulatory T lymphocyte, systemic lupus erythematosus/dt [Drug Therapy], systemic lupus erythematosus/et [Etiology], upregulation, cyclophosphamide/dt [Drug Therapy], cytotoxic T lymphocyte antigen 4/ec [Endogenous Compound], gamma interferon/ec [Endogenous Compound], glucocorticoid/dt [Drug Therapy], immunoglobulin G/ec [Endogenous Compound], interleukin 10/dt [Drug Therapy], interleukin 10/ec [Endogenous Compound], interleukin 2/ct [Clinical Trial], interleukin 2/dt [Drug Therapy], rituximab/dt [Drug Therapy], STAT3 protein/ec [Endogenous Compound], FOXP3 gene, protein depletion, acute kidney failure/dt [Drug Therapy], acute kidney failure/et [Etiology], ANCA associated vasculitis/dt [Drug Therapy], ANCA associated vasculitis/et [Etiology], antigen expression, apoptosis, article, autoimmunity, CD25+ T lymphocyte, CD4+ T lymphocyte, CD8+ T lymphocyte, cell infiltration, cell therapy, cytokine production, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/39912
Nephrology
LibKey Link

المؤلفون: Harris J., Godsell J., Nold-Petry C.A., Hoi A., Nold M.F., Morand E.F., Rudloff I.

مصطلحات الفهرس: lupus erythematosus nephritis, major clinical study, male, peripheral blood mononuclear cell, priority journal, protein blood level, SLEDAI, systemic lupus erythematosus/dt [Drug Therapy], systemic lupus erythematosus/et [Etiology], antiinflammatory agent/pd [Pharmacology], APRIL protein/ec [Endogenous Compound], azathioprine/dt [Drug Therapy], CpG oligodeoxynucleotide, cytokine/ec [Endogenous Compound], glucocorticoid/dt [Drug Therapy], hydroxychloroquine/dt [Drug Therapy], imiquimod, interleukin 10/ec [Endogenous Compound], interleukin 6/ec [Endogenous Compound], methotrexate/dt [Drug Therapy], monocyte chemotactic protein 1/ec [Endogenous Compound], mycophenolic acid/dt [Drug Therapy], prednisolone/dt [Drug Therapy], recombinant cytokine/pd [Pharmacology], small interfering RNA, unclassified drug, interleukin 38/ec [Endogenous Compound], recombinant interleukin 38/pd [Pharmacology], disease activity, adult, aged, antiinflammatory activity, article, brain vasculitis, cell stimulation, cohort analysis, controlled study, cytokine release, disease association, disease severity, enzyme linked immunosorbent assay, evidence based practice, female, high risk patient, human, human cell, immunosuppressive treatment, longitudinal study, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/41116
Arthritis and Rheumatology
Click here for full text options
LibKey Link

المؤلفون: Harris J., Lang T., Foote A., Lee J.P.W., Morand E.F.

مصطلحات الفهرس: gene expression, genetic association, genetic polymorphism, human, miliary tuberculosis, nonhuman, phase 1 clinical trial (topic), phosphorylation, signal transduction, single nucleotide polymorphism, solid tumor, systemic lupus erythematosus/et [Etiology], upregulation, migration inhibition factor/ec [Endogenous Compound], mitogen activated protein kinase/ec [Endogenous Compound], review, autophagy, cell proliferation, disease severity, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/40864
Frontiers in Immunology
Click here for full text options
LibKey Link

المؤلفون: Harris J., Godsell J., Nold-Petry C.A., Hoi A., Nold M.F., Morand E.F., Rudloff I.

مصطلحات الفهرس: lupus erythematosus nephritis, major clinical study, male, peripheral blood mononuclear cell, priority journal, protein blood level, SLEDAI, systemic lupus erythematosus/dt [Drug Therapy], systemic lupus erythematosus/et [Etiology], antiinflammatory agent/pd [Pharmacology], APRIL protein/ec [Endogenous Compound], azathioprine/dt [Drug Therapy], CpG oligodeoxynucleotide, cytokine/ec [Endogenous Compound], glucocorticoid/dt [Drug Therapy], hydroxychloroquine/dt [Drug Therapy], imiquimod, interleukin 10/ec [Endogenous Compound], interleukin 6/ec [Endogenous Compound], methotrexate/dt [Drug Therapy], monocyte chemotactic protein 1/ec [Endogenous Compound], mycophenolic acid/dt [Drug Therapy], prednisolone/dt [Drug Therapy], recombinant cytokine/pd [Pharmacology], small interfering RNA, unclassified drug, interleukin 38/ec [Endogenous Compound], recombinant interleukin 38/pd [Pharmacology], disease activity, adult, aged, antiinflammatory activity, article, brain vasculitis, cell stimulation, cohort analysis, controlled study, cytokine release, disease association, disease severity, enzyme linked immunosorbent assay, evidence based practice, female, high risk patient, human, human cell, immunosuppressive treatment, longitudinal study, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/41116
Arthritis and Rheumatology
LibKey Link

المؤلفون: Harris J., Lang T., Foote A., Lee J.P.W., Morand E.F.

مصطلحات الفهرس: gene expression, genetic association, genetic polymorphism, human, miliary tuberculosis, nonhuman, phase 1 clinical trial (topic), phosphorylation, signal transduction, single nucleotide polymorphism, solid tumor, systemic lupus erythematosus/et [Etiology], upregulation, migration inhibition factor/ec [Endogenous Compound], mitogen activated protein kinase/ec [Endogenous Compound], review, autophagy, cell proliferation, disease severity, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/40864
Frontiers in Immunology
LibKey Link

المؤلفون: Littlejohn G., Hoi A.

مصطلحات الفهرس: rheumatoid arthritis, systemic lupus erythematosus/dt [Drug Therapy], systemic lupus erythematosus/et [Etiology], T lymphocyte, T lymphocyte activation, treatment response, abatacept/ct [Clinical Trial], abatacept/dt [Drug Therapy], azathioprine/dt [Drug Therapy], cyclophosphamide/dt [Drug Therapy], mycophenolic acid/dt [Drug Therapy], prednisolone/dt [Drug Therapy], rituximab/dt [Drug Therapy], monotherapy, cell expansion, drug efficacy, drug mechanism, human, immunoreactivity, lupus erythematosus nephritis, nonhuman, phase 2 clinical trial (topic), phase 3 clinical trial (topic), psoriatic arthritis, randomized controlled trial (topic), review, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/41842
Click here for full text options
LibKey Link

المؤلفون: Littlejohn G., Hoi A.

مصطلحات الفهرس: rheumatoid arthritis, systemic lupus erythematosus/dt [Drug Therapy], systemic lupus erythematosus/et [Etiology], T lymphocyte, T lymphocyte activation, treatment response, abatacept/ct [Clinical Trial], abatacept/dt [Drug Therapy], azathioprine/dt [Drug Therapy], cyclophosphamide/dt [Drug Therapy], mycophenolic acid/dt [Drug Therapy], prednisolone/dt [Drug Therapy], rituximab/dt [Drug Therapy], monotherapy, cell expansion, drug efficacy, drug mechanism, human, immunoreactivity, lupus erythematosus nephritis, nonhuman, phase 2 clinical trial (topic), phase 3 clinical trial (topic), psoriatic arthritis, randomized controlled trial (topic), review, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/41842
Click here for full text options
LibKey Link

المؤلفون: Hoi A.Y., Connelly K., Morand E.F.

مصطلحات الفهرس: clinical feature, cohort analysis, disease activity, disease predisposition, disease severity, ethnic difference, ethnic group, health care disparity, human, immunosuppressive treatment, kidney disease, mental disease/co [Complication], priority journal, review, systemic lupus erythematosus/et [Etiology], autoantibody/ec [Endogenous Compound], gastrointestinal disease, Asian, Australia, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/27679
Click here for full text options
LibKey Link

المؤلفون: Bourke P., Bossingham D., Mackay F., Morand E.F., Vincent F.B.

مصطلحات الفهرس: genetic variability, glomerulonephritis, health status, heart block, hemolytic anemia, human, indigenous people, innate immunity, leukopenia, life expectancy, lupus erythematosus nephritis, lymphocytopenia, mouth ulcer, multiple sclerosis, nonhuman, obesity, pathogenesis, pathophysiology, perinatal mortality, phenotype, photosensitivity, plasmacytoid dendritic cell, polyarthritis, population genetics, priority journal, psoriatic arthritis, quality of life, rash, review, rheumatic heart disease, rheumatoid arthritis/et [Etiology], sclerosis, skin infection, smoking, spondylitis, spondyloarthropathy/et [Etiology], substance abuse, systemic lupus erythematosus/dt [Drug Therapy], systemic lupus erythematosus/et [Etiology], systemic sclerosis/et [Etiology], thrombocytopenia, ultraviolet radiation, autoantibody/ec [Endogenous Compound], belimumab/ct [Clinical Trial], belimumab/dt [Drug Therapy], HLA B27 antigen/ec [Endogenous Compound], interferon/ec [Endogenous Compound], major histocompatibility antigen class 2/ec [Endogenous Compound], toll like receptor 7/ec [Endogenous Compound], toll like receptor 9/ec [Endogenous Compound], tumor necrosis factor/ec [Endogenous Compound], heredity, alcohol consumption, allergic glomerulonephritis, ankylosing spondylitis, antiphospholipid syndrome, Australia, autoimmune disease/et [Etiology], autoimmunity, bacterial infection, bullous pemphigoid, cell hyperplasia, Crohn disease, disease duration, disease severity, domestic violence, ethnicity, genetic difference, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/27538
Click here for full text options
LibKey Link

المؤلفون: Hoi A.Y., Connelly K., Morand E.F.

مصطلحات الفهرس: clinical feature, cohort analysis, disease activity, disease predisposition, disease severity, ethnic difference, ethnic group, health care disparity, human, immunosuppressive treatment, kidney disease, mental disease/co [Complication], priority journal, review, systemic lupus erythematosus/et [Etiology], autoantibody/ec [Endogenous Compound], gastrointestinal disease, Asian, Australia, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/27679
LibKey Link

المؤلفون: Bourke P., Bossingham D., Mackay F., Morand E.F., Vincent F.B.

مصطلحات الفهرس: genetic variability, glomerulonephritis, health status, heart block, hemolytic anemia, human, indigenous people, innate immunity, leukopenia, life expectancy, lupus erythematosus nephritis, lymphocytopenia, mouth ulcer, multiple sclerosis, nonhuman, obesity, pathogenesis, pathophysiology, perinatal mortality, phenotype, photosensitivity, plasmacytoid dendritic cell, polyarthritis, population genetics, priority journal, psoriatic arthritis, quality of life, rash, review, rheumatic heart disease, rheumatoid arthritis/et [Etiology], sclerosis, skin infection, smoking, spondylitis, spondyloarthropathy/et [Etiology], substance abuse, systemic lupus erythematosus/dt [Drug Therapy], systemic lupus erythematosus/et [Etiology], systemic sclerosis/et [Etiology], thrombocytopenia, ultraviolet radiation, autoantibody/ec [Endogenous Compound], belimumab/ct [Clinical Trial], belimumab/dt [Drug Therapy], HLA B27 antigen/ec [Endogenous Compound], interferon/ec [Endogenous Compound], major histocompatibility antigen class 2/ec [Endogenous Compound], toll like receptor 7/ec [Endogenous Compound], toll like receptor 9/ec [Endogenous Compound], tumor necrosis factor/ec [Endogenous Compound], heredity, alcohol consumption, allergic glomerulonephritis, ankylosing spondylitis, antiphospholipid syndrome, Australia, autoimmune disease/et [Etiology], autoimmunity, bacterial infection, bullous pemphigoid, cell hyperplasia, Crohn disease, disease duration, disease severity, domestic violence, ethnicity, genetic difference, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/27538
LibKey Link

المؤلفون: Miller M.H.

مصطلحات الفهرس: letter, male, priority journal, systemic lupus erythematosus/et [Etiology], human, sex hormone, impotence/et [Etiology], Letter

URL: Click here for full text options
LibKey Link

المؤلفون: Hicks M.J., Bullard D.C., Panoskaltsis-Mortari A., Zinn K.R., Kesterson R.A., Zhang J., Samuel S., Hickey M.J., He X., Schoeb T.R.

مصطلحات الفهرس: down regulation, endothelium cell, glomerulonephritis/et [Etiology], inflammation, kidney, leukocyte migration, lupus erythematosus/et [Etiology], mortality, mouse, mouse strain, nonhuman, priority journal, protein deficiency, disease course, animal experiment, animal model, animal tissue, article, autoimmune disease, cell infiltration, controlled study, cytokine production, protein expression, supernatant, systemic lupus erythematosus/et [Etiology], Fas antigen/ec [Endogenous Compound], monocyte chemotactic protein 1/ec [Endogenous Compound], P selectin glycoprotein ligand 1/ec [Endogenous Compound], PADGEM protein/ec [Endogenous Compound], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/32130
Click here for full text options
LibKey Link

المؤلفون: Hickey M.J.

مصطلحات الفهرس: endothelium cell, gene deletion, gene mutation, gene targeting, laboratory, leukocyte, microvasculature, molecular dynamics, mouse, mouse strain, nonhuman, protein expression, protein function, review, systemic lupus erythematosus/et [Etiology], upregulation, cell adhesion molecule/ec [Endogenous Compound], Fas antigen/ec [Endogenous Compound], pathogenesis, cell interaction, disease course, disease predisposition, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/32735
Click here for full text options
LibKey Link

المؤلفون: Hoi A.Y., Littlejohn G.O.

مصطلحات الفهرس: nonhuman, pathogenesis, review, rheumatoid arthritis/dt [Drug Therapy], systemic lupus erythematosus/dt [Drug Therapy], systemic lupus erythematosus/et [Etiology], T lymphocyte activation, treatment outcome, treatment response, abatacept/ae [Adverse Drug Reaction], abatacept/ct [Clinical Trial], abatacept/cb [Drug Combination], abatacept/do [Drug Dose], abatacept/dt [Drug Therapy], abatacept/pd [Pharmacology], abatacept/sc [Subcutaneous Drug Administration], azathioprine/cb [Drug Combination], azathioprine/dt [Drug Therapy], CD28 antigen/ec [Endogenous Compound], corticosteroid/cb [Drug Combination], corticosteroid/dt [Drug Therapy], cyclophosphamide/cb [Drug Combination], cyclophosphamide/dt [Drug Therapy], HLA B7 antigen/ec [Endogenous Compound], methotrexate/cb [Drug Combination], methotrexate/dt [Drug Therapy], mycophenolic acid 2 morpholinoethyl ester/cb [Drug Combination], mycophenolic acid 2 morpholinoethyl ester/dt [Drug Therapy], immune response, antigen presenting cell, B lymphocyte, disease severity, drug efficacy, drug indication, drug safety, drug treatment failure, human, immunosuppressive treatment, infection/si [Side Effect], loading drug dose, lupus erythematosus nephritis/co [Complication], lupus erythematosus nephritis/dt [Drug Therapy], Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28344
Click here for full text options
LibKey Link